Retrophin considering acquisition of Raptor Pharmaceutical- Bloomberg
:Retrophin Inc considering acquisition of Raptor Pharmaceutical Corp - Bloomberg, citing sources.
Latest Developments forRetrophin Inc
- Retrophin Expects Total Net Product Sales Of Approximately $155 Million In 2018
- Retrophin Enters Into Future Acquisition Right, Joint Development Agreement With Censa Pharma
- Retrophin And Censa Pharmaceuticals Enter Into Strategic Collaboration To Advance Cnsa-001
- Retrophin reports third quarter 2017 financial results